89 related articles for article (PubMed ID: 2500332)
1. Estrogen regulation of human breast cancer cell line MCF-7 tissue plasminogen activator.
Dickerman HW; Martinez HL; Seeger JI; Kumar SA
Endocrinology; 1989 Jul; 125(1):492-500. PubMed ID: 2500332
[TBL] [Abstract][Full Text] [Related]
2. Suppression of estrogen-regulated extracellular tissue plasminogen activator activity of MCF-7 cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Gierthy JF; Lincoln DW; Gillespie MB; Seeger JI; Martinez HL; Dickerman HW; Kumar SA
Cancer Res; 1987 Dec; 47(23):6198-203. PubMed ID: 3119194
[TBL] [Abstract][Full Text] [Related]
3. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
Pink JJ; Jordan VC
Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
[TBL] [Abstract][Full Text] [Related]
4. The influence of antiestrogens on the release of plasminogen activator (uPA) by MDA-MB-231 and MCF-7 breast cancer cells.
Abidi SM; Howard EW; Dmytryk JJ; Pento JT
Clin Exp Metastasis; 1998 Apr; 16(3):235-41. PubMed ID: 9568641
[TBL] [Abstract][Full Text] [Related]
5. Enhanced production of tissue-type plasminogen activator by estradiol in a novel type variant of human breast cancer MCF-7 cell line.
Mizoguchi H; Uchiumi T; Ono M; Kohno K; Kuwano M
Biochim Biophys Acta; 1990 May; 1052(3):475-82. PubMed ID: 2112958
[TBL] [Abstract][Full Text] [Related]
6. Effects of serum and insulin on the sensitivity of the human breast cancer cell line MCF-7 to estrogen and antiestrogens.
Butler WB; Kelsey WH; Goran N
Cancer Res; 1981 Jan; 41(1):82-8. PubMed ID: 7004631
[TBL] [Abstract][Full Text] [Related]
7. Estradiol preferentially enhances extracellular tissue plasminogen activators of MCF-7 breast cancer cells.
Ryan TJ; Seeger JI; Kumar SA; Dickerman HW
J Biol Chem; 1984 Dec; 259(23):14324-7. PubMed ID: 6542103
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activators in human breast cancer cell lines: hormonal regulation and properties.
Mangel WF; Toledo DL; Nardulli AM; Reiner GC; Norman MJ; Katzenellenbogen BS
J Steroid Biochem; 1988; 30(1-6):79-88. PubMed ID: 3386280
[TBL] [Abstract][Full Text] [Related]
9. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.
Katzenellenbogen BS; Norman MJ; Eckert RL; Peltz SW; Mangel WF
Cancer Res; 1984 Jan; 44(1):112-9. PubMed ID: 6537799
[TBL] [Abstract][Full Text] [Related]
10. Effects of thrombin on steroid-modulated cultured endometrial stromal cell fibrinolytic potential.
Lockwood CJ; Krikun G; Aigner S; Schatz F
J Clin Endocrinol Metab; 1996 Jan; 81(1):107-12. PubMed ID: 8550736
[TBL] [Abstract][Full Text] [Related]
11. Modulation of plasminogen activator systems by matrix components in two breast cancer cell lines: MCF-7 and MDA-MB-231.
Pourreau-Schneider N; Delori P; Boutière B; Arnoux D; George F; Sampol J; Martin PM
J Natl Cancer Inst; 1989 Feb; 81(4):259-66. PubMed ID: 2492346
[TBL] [Abstract][Full Text] [Related]
12. Laminin and estradiol regulation of the plasminogen-activator system in MCF-7 breast-carcinoma cells.
Sonohara S; Mira-y-Lopez R; Brentani MM
Int J Cancer; 1998 Mar; 76(1):77-85. PubMed ID: 9533765
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of growth and invasiveness of MCF-7 breast cancer cells by antiestrogens.
Thompson EW; Reich R; Shima TB; Albini A; Graf J; Martin GR; Dickson RB; Lippman ME
Cancer Res; 1988 Dec; 48(23):6764-8. PubMed ID: 2846159
[TBL] [Abstract][Full Text] [Related]
14. Regulation of pS2 gene expression by affinity labeling and reversibly binding estrogens and antiestrogens: comparison of effects on the native gene and on pS2-chloramphenicol acetyltransferase fusion genes transfected into MCF-7 human breast cancer cells.
Weaver CA; Springer PA; Katzenellenbogen BS
Mol Endocrinol; 1988 Oct; 2(10):936-45. PubMed ID: 2460749
[TBL] [Abstract][Full Text] [Related]
15. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens.
Katzenellenbogen BS; Kendra KL; Norman MJ; Berthois Y
Cancer Res; 1987 Aug; 47(16):4355-60. PubMed ID: 3607768
[TBL] [Abstract][Full Text] [Related]
16. Estradiol modulation of plasminogen activator production in organ cultures of human breast carcinomas: correlation with clinical outcome of anti-estrogen therapy.
Mira-y-Lopez R; Osborne MP; DePalo AJ; Ossowski L
Int J Cancer; 1991 Apr; 47(6):827-32. PubMed ID: 1901298
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator activity during decidualization of human endometrial stromal cells is regulated by plasminogen activator inhibitor 1.
Schatz F; Aigner S; Papp C; Toth-Pal E; Hausknecht V; Lockwood CJ
J Clin Endocrinol Metab; 1995 Aug; 80(8):2504-10. PubMed ID: 7629251
[TBL] [Abstract][Full Text] [Related]
18. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression.
Lockwood CJ; Krikun G; Papp C; Aigner S; Schatz F
J Clin Endocrinol Metab; 1995 Apr; 80(4):1100-5. PubMed ID: 7714076
[TBL] [Abstract][Full Text] [Related]
19. Responses to retinoic acid of tamoxifen-sensitive and -resistant sublines of human breast cancer cell line MCF-7.
Butler WB; Fontana JA
Cancer Res; 1992 Nov; 52(22):6164-7. PubMed ID: 1423259
[TBL] [Abstract][Full Text] [Related]
20. Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells.
Sheen YY; Ruh TS; Mangel WF; Katzenellenbogen BS
Cancer Res; 1985 Sep; 45(9):4192-9. PubMed ID: 4040807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
